GlassScriptPhysician profile
Betsy G Weiss
NPI 1760578678
$1,601.27
in general payments reported to CMS, 2019-2025
21 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2023: $608 · 2024: $473 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.12 |
| Education | $113.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $502.43 | 2021-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $148.94 | 2023-2025 | |
| Myovant Sciences INC. | $115.53 | 2021 | |
| Abbvie INC. | $103.60 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $95.74 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $95.60 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $82.85 | 2024-2025 | |
| Pfizer INC. | $57.21 | 2023-2024 | |
| Agile Therapeutics, INC. | $55.00 | 2023-2024 | Twirla |
| Exact Sciences Corporation | $54.76 | 2024-2025 | Cologuard Collection Kit |
| Millicent US INC | $52.83 | 2024-2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $42.58 | 2023-2024 | Slynd |
| Mycovia Pharmaceuticals, INC. | $39.37 | 2023 | Vivjoa |
| Baxter Healthcare | $29.31 | 2025 | Perclot |
| Optumhealth Care Solutions, LLC | $27.18 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18.77 | 2023 | Nexplanon |
| Coopersurgical, INC. | $18.25 | 2023 | Endosee |
| Ascend Therapeutics US, LLC | $17.91 | 2024 | |
| Daiichi Sankyo INC. | $16.09 | 2023 | Injectafer |
| Avion Pharmaceuticals | $14.65 | 2023 | Balcoltra |
| Mission Pharmacal Company | $12.67 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.